CONMED (CNMD) Stock Price, News & Analysis

-0.59 (-0.79%)
(As of 10:56 AM ET)
Today's Range
50-Day Range
52-Week Range
32,137 shs
Average Volume
572,018 shs
Market Capitalization
$2.28 billion
P/E Ratio
Dividend Yield
Price Target

CONMED MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.86 Rating Score
44.3% Upside
$107.86 Price Target
Short Interest
11.30% of Shares Sold Short
Dividend Strength
Based on Four Factors
Upright™ Environmental Score
News Sentiment
0.55mentions of CONMED in the last 14 days
Based on 5 Articles This Week
Insider Trading
Acquiring Shares
$446,733 Bought Last Quarter
Proj. Earnings Growth
From $4.30 to $5.51 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.99 out of 5 stars

Medical Sector

5th out of 914 stocks

Electromedical Equipment Industry

1st out of 19 stocks

CNMD stock logo


CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

CNMD Stock Price History

CNMD Stock News Headlines

CONMED Co. (NYSE:CNMD) Director Buys $99,872.92 in Stock
CONMED First Quarter 2024 Earnings: Beats Expectations
Analyst Scoreboard: 5 Ratings For Conmed
Conmed: Q1 Earnings Snapshot
Conmed Corp. Q1 Income Climbs, but misses estimates
Conmed is about to announce its earnings — here's what to expect
Should You Invest in CONMED (CNMD)?
See More Headlines
Receive CNMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CONMED and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 4/5 Dividend
Dividend Payable
Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Electromedical equipment
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Moderate Buy
Rating Score (0-4)
Research Coverage
7 Analysts


Net Income
$64.46 million
Pretax Margin


Sales & Book Value

Annual Sales
$1.24 billion
Cash Flow
$6.05 per share
Book Value
$27.13 per share


Free Float
Market Cap
$2.30 billion
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

CNMD Stock Analysis - Frequently Asked Questions

Should I buy or sell CONMED stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CONMED in the last year. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CNMD shares.
View CNMD analyst ratings
or view top-rated stocks.

What is CONMED's stock price target for 2024?

7 analysts have issued 12 month price targets for CONMED's stock. Their CNMD share price targets range from $75.00 to $141.00. On average, they anticipate the company's stock price to reach $107.86 in the next twelve months. This suggests a possible upside of 44.5% from the stock's current price.
View analysts price targets for CNMD
or view top-rated stocks among Wall Street analysts.

How have CNMD shares performed in 2024?

CONMED's stock was trading at $109.51 at the beginning of 2024. Since then, CNMD shares have decreased by 31.9% and is now trading at $74.62.
View the best growth stocks for 2024 here

Are investors shorting CONMED?

CONMED saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 3,480,000 shares, a drop of 10.5% from the April 15th total of 3,890,000 shares. Based on an average daily volume of 543,900 shares, the days-to-cover ratio is presently 6.4 days.
View CONMED's Short Interest

When is CONMED's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 24th 2024.
View our CNMD earnings forecast

How were CONMED's earnings last quarter?

CONMED Co. (NYSE:CNMD) announced its quarterly earnings data on Wednesday, April, 24th. The company reported $0.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.74 by $0.05. The business had revenue of $312.27 million for the quarter, compared to analysts' expectations of $307.06 million. CONMED had a trailing twelve-month return on equity of 13.78% and a net margin of 6.53%.

How often does CONMED pay dividends? What is the dividend yield for CONMED?

CONMED announced a quarterly dividend on Monday, February 26th. Shareholders of record on Friday, March 15th will be given a dividend of $0.20 per share on Friday, April 5th. This represents a $0.80 dividend on an annualized basis and a yield of 1.07%. The ex-dividend date is Thursday, March 14th.
Read our dividend analysis for CNMD

Is CONMED a good dividend stock?

CONMED (NYSE:CNMD) pays an annual dividend of $0.80 per share and currently has a dividend yield of 1.07%. The dividend payout ratio is 30.65%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CNMD will have a dividend payout ratio of 14.52% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CNMD.

What ETFs hold CONMED's stock?
What guidance has CONMED issued on next quarter's earnings?

CONMED issued an update on its FY 2024 earnings guidance on Wednesday, April, 24th. The company provided EPS guidance of 4.250-4.350 for the period, compared to the consensus earnings per share estimate of 4.330. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion.

Who are CONMED's major shareholders?

CONMED's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (11.22%), Earnest Partners LLC (7.70%), Capital Research Global Investors (4.74%), Champlain Investment Partners LLC (4.23%), Principal Financial Group Inc. (1.98%) and Jennison Associates LLC (1.13%). Insiders that own company stock include Barbara J Schwarzentraub, Brian Concannon, Curt R Hartman, Daniel S Jonas, John D Ferrell, Johonna Marie Pelletier, Martha Goldberg Aronson, Pat Beyer, Peter K Shagory, Stanley W Peters III, Todd W Garner and Todd W Garner.
View institutional ownership trends

How do I buy shares of CONMED?

Shares of CNMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:CNMD) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners